An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we move away from sending confirmatory results via fax and implement sending them directly to your email.
Check out the Communication page for the complete details by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...